» Articles » PMID: 19608921

Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA

Overview
Journal Science
Specialty Science
Date 2009 Jul 18
PMID 19608921
Citations 225
Authors
Affiliations
Soon will be listed here.
Abstract

Genomic expansions of simple tandem repeats can give rise to toxic RNAs that contain expanded repeats. In myotonic dystrophy, the expression of expanded CUG repeats (CUGexp) causes abnormal regulation of alternative splicing and neuromuscular dysfunction. We used a transgenic mouse model to show that derangements of myotonic dystrophy are reversed by a morpholino antisense oligonucleotide, CAG25, that binds to CUGexp RNA and blocks its interaction with muscleblind-like 1 (MBNL1), a CUGexp-binding protein. CAG25 disperses nuclear foci of CUGexp RNA and reduces the overall burden of this toxic RNA. As MBNL1 is released from sequestration, the defect of alternative splicing regulation is corrected, thereby restoring ion channel function. These findings suggest an alternative use of antisense methods, to inhibit deleterious interactions of proteins with pathogenic RNAs.

Citing Articles

Use of HSA female mice as a model for the study of myotonic dystrophy type I.

Carrascosa-Saez M, Colom-Rodrigo A, Gonzalez-Martinez I, Perez-Gomez R, Garcia-Rey A, Piqueras-Losilla D Lab Anim (NY). 2025; .

PMID: 40016516 DOI: 10.1038/s41684-025-01506-7.


Functions of the Muscleblind-like protein family and their role in disease.

Zhou H, Xu J, Pan L Cell Commun Signal. 2025; 23(1):97.

PMID: 39966885 PMC: 11837677. DOI: 10.1186/s12964-025-02102-5.


The evolution and application of RNA-focused small molecule libraries.

Taghavi A, Springer N, Zanon P, Li Y, Li C, Childs-Disney J RSC Chem Biol. 2025; .

PMID: 39957993 PMC: 11824871. DOI: 10.1039/d4cb00272e.


The Splice Index as a prognostic biomarker of strength and function in myotonic dystrophy type 1.

Provenzano M, Ikegami K, Bates K, Gaynor A, Hartman J, Jones A J Clin Invest. 2025; 135(4).

PMID: 39836447 PMC: 11827844. DOI: 10.1172/JCI185426.


Evaluation of an Antisense Oligonucleotide Targeting CAG Repeats: A Patient-Customized Therapy Study for Huntington's Disease.

Ocampo-Ortega S, Sierra-Sanchez V, Blancas-Napoles C, Gonzalez-Carteno A, Mera-Jimenez E, Macias-Perez M Life (Basel). 2025; 14(12.

PMID: 39768315 PMC: 11677511. DOI: 10.3390/life14121607.


References
1.
TANEJA K, McCurrach M, Schalling M, Housman D, Singer R . Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol. 1995; 128(6):995-1002. PMC: 2120416. DOI: 10.1083/jcb.128.6.995. View

2.
Mankodi A, Takahashi M, Jiang H, Beck C, Bowers W, Moxley R . Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell. 2002; 10(1):35-44. DOI: 10.1016/s1097-2765(02)00563-4. View

3.
Kuyumcu-Martinez N, Wang G, Cooper T . Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell. 2007; 28(1):68-78. PMC: 2083558. DOI: 10.1016/j.molcel.2007.07.027. View

4.
Osborne R, Lin X, Welle S, Sobczak K, ORourke J, Swanson M . Transcriptional and post-transcriptional impact of toxic RNA in myotonic dystrophy. Hum Mol Genet. 2009; 18(8):1471-81. PMC: 2664149. DOI: 10.1093/hmg/ddp058. View

5.
Summerton J . Morpholino antisense oligomers: the case for an RNase H-independent structural type. Biochim Biophys Acta. 2000; 1489(1):141-58. DOI: 10.1016/s0167-4781(99)00150-5. View